AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FIBROGEN INC Director's Dealing 2023

Sep 8, 2023

34576_dirs_2023-09-08_9942b3bb-a40d-4241-9c7a-28b8781f03c5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2023-09-06

Reporting Person: Chung Christine (SVP, China Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-06	Common Stock	F	3308	$0.9631	Disposed	353019	Direct

Footnotes

F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.